Skip to main content

What the FDA labels say about taking them together

Pomalidomide and thalidomide

Pomalidomide's FDA label of February 26, 2025 names thalidomide in its boxed warning section; the thalidomide label PlainMeds reads does not name pomalidomide.

Check it at the source: the pomalidomide FDA label on DailyMed (effective February 26, 2025, Celgene Corporation); the thalidomide FDA label on DailyMed (effective March 24, 2023, Celgene Corporation).

What does the pomalidomide label say about thalidomide?

Pomalidomide label, boxed warning

Thalidomide is a known human teratogen that causes severe life-threatening birth defects ( 4 , 5.1 , 8.1 ).

Pomalidomide label, warnings and precautions

Thalidomide is a known human teratogen that causes severe birth defects or embryo-fetal death [see Use in Specific Populations (8.1) ].

Source: FDA drug label (Pomalyst), NDA204026 (Bristol), as published by Celgene Corporation, effective February 26, 2025 (SPL set 2b25ef01-5c9e-11e1-b86c-0800200c9a66), via openFDA; the full label on DailyMed

What does the thalidomide label say about pomalidomide?

Thalidomide's label (effective March 24, 2023) does not name pomalidomide in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Thalomid), NDA020785 (Bristol-Myers), as published by Celgene Corporation, effective March 24, 2023 (SPL set 2eda833b-1357-4ed4-a093-194524fcb061), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

11Pomalidomide generic labelers
0Thalidomide generic labelers
PomalidomideThalidomide
Labeled forLeukemia, lymphoma and myelomaLeukemia, lymphoma and myeloma
Boxed warningYesYes
Pharmacy cost (NADAC)n/an/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?